Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

47.90 -1.93 (-3.87%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pulse Biosciences, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

January 13, 2025

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

January 10, 2025

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 03, 2025

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

December 23, 2024

From Pulse Biosciences, Inc.

Via Business Wire

PLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024 ↗

August 22, 2024

Pulse Biosciences just reported results for the second quarter of 2024.

Via InvestorPlace

Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants

December 19, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery

December 17, 2024

From Pulse Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 01, 2024

Via Benzinga

Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association

October 31, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results

October 30, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology

October 30, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024

October 21, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday ↗

August 13, 2024

Via Benzinga

Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results

August 12, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors

August 12, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System

August 08, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences

August 01, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024

July 29, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns ↗

July 12, 2024

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.

Via Benzinga

Topics Economy

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 08, 2024

Via Benzinga

S&P 500, Nasdaq Extend Record Highs; Dow Up Triple Digits ↗

July 08, 2024

The Dow Jones Industrial Average is up triple digits midday, as investors look ahead to this week's inflation data.

Via Talk Markets

Topics Economy Stocks

Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday ↗

July 08, 2024

Via Benzinga

Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation

July 08, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces the Closing of its Rights Offering

July 03, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering

June 28, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 31, 2024

Via Benzinga

Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000

May 20, 2024

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting

May 16, 2024

From Pulse Biosciences, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.